Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model
Sharareh Eskandari1, Jaleh Varshosaz1, Mohsen Minaiyan2, Majid Tabbakhian11Department of Pharmaceutics, 2Department of Pharmacology, School of Pharmacy and Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, IranAbstract: The treatment of brain disorders...
Guardado en:
Autores principales: | Sharareh Eskandari, Jaleh Varshosaz, Mohsen Minaiyan, et al |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/04c08196c82049e898820815e8aa23b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery
por: Yin-Ku Lin, et al.
Publicado: (2010) -
Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles – Formulation and Pharmacodynamic Assessment
por: Awadeen RH, et al.
Publicado: (2020) -
Mucoadhesive, Thermoreversible Hydrogel, Containing Tetracaine-Loaded Nanostructured Lipid Carriers for Topical, Intranasal Needle-Free Anesthesia
por: Giovana Maria Fioramonti Calixto, et al.
Publicado: (2021) -
Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers
por: Chen Y, et al.
Publicado: (2012) -
In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration
por: Fang M, et al.
Publicado: (2012)